Successful treatment for diffuse large B-cell lymphoma in a Japanese adolescent with PIK3CD germ-line mutation: stem cell transplantation after reduced-intensity conditioning

Hiroshi Yagasaki; Maiko Hirai; Koji Kanezawa; Masaru Ueno; Hiroyuki Hao; Shinobu Masuda; Masahiko Sugitani; Ichiro Morioka

doi:10.1007/s00277-022-04809-8

Successful treatment for diffuse large B-cell lymphoma in a Japanese adolescent with PIK3CD germ-line mutation: stem cell transplantation after reduced-intensity conditioning

Ann Hematol. 2022 Jul;101(7):1617-1619. doi: 10.1007/s00277-022-04809-8. Epub 2022 Mar 5.

Authors

Hiroshi Yagasaki¹, Maiko Hirai², Koji Kanezawa², Masaru Ueno², Hiroyuki Hao³, Shinobu Masuda⁴, Masahiko Sugitani^{3

5}, Ichiro Morioka²

Affiliations

¹ Pediatrics, Nihon University School of Medicine, Tokyo, Japan. yagasaki.hiroshi@nihon-u.ac.jp.
² Pediatrics, Nihon University School of Medicine, Tokyo, Japan.
³ Division of Human Pathology, Department of Pathology, Nihon University School of Medicine, Tokyo, Japan.
⁴ Division of Oncologic Pathology, Department of Pathology and Microbiology, Nihon University School of Medicine, Tokyo, Japan.
⁵ Department of Pathology, Ageo Central General Hospital, Saitama, Japan.

PMID: 35247100
DOI: 10.1007/s00277-022-04809-8

No abstract available

Keywords: Bone marrow transplantation; Diffuse large B-cell lymphoma; Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue; PIK3CD; Reduced-intensity conditioning; Rituximab.

Publication types

Letter

MeSH terms

Adolescent
Class I Phosphatidylinositol 3-Kinases / genetics
Germ-Line Mutation
Hematopoietic Stem Cell Transplantation*
Humans
Japan
Lymphoma, B-Cell, Marginal Zone* / pathology
Lymphoma, Large B-Cell, Diffuse* / genetics
Lymphoma, Large B-Cell, Diffuse* / therapy
Transplantation Conditioning

Substances

Class I Phosphatidylinositol 3-Kinases
PIK3CD protein, human